In a cross-sectional study, Trotti and colleagues examined the association of orexin, dementia biomarkers and sleep disturbances in four clinical populations: Alzheimer’s Disease (AD), frontotemporal dementia (FTD), DLB and healthy controls [54]. Here, HCRT is linked to frontotemporal dementia.